- Home
- BDC vs APLS Comparison
BDC vs APLS Comparison
Compare BDC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDC
- APLS
- Stock Information
- Founded
- BDC 1902
- APLS 2009
- Country
- BDC United States
- APLS United States
- Employees
- BDC N/A
- APLS N/A
- Industry
- BDC Telecommunications Equipment
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- BDC Telecommunications
- APLS Health Care
- Exchange
- BDC Nasdaq
- APLS Nasdaq
- Market Cap
- BDC 4.1B
- APLS 3.3B
- IPO Year
- BDC 1993
- APLS 2017
- Fundamental
- Price
- BDC $101.12
- APLS $22.68
- Analyst Decision
- BDC Strong Buy
- APLS Buy
- Analyst Count
- BDC 5
- APLS 18
- Target Price
- BDC $130.20
- APLS $45.53
- AVG Volume (30 Days)
- BDC 329.9K
- APLS 1.8M
- Earning Date
- BDC 05-01-2025
- APLS 05-06-2025
- Dividend Yield
- BDC 0.20%
- APLS N/A
- EPS Growth
- BDC N/A
- APLS N/A
- EPS
- BDC 4.80
- APLS N/A
- Revenue
- BDC $2,460,979,000.00
- APLS $781,367,000.00
- Revenue This Year
- BDC $9.96
- APLS $12.95
- Revenue Next Year
- BDC $5.43
- APLS $21.35
- P/E Ratio
- BDC $20.93
- APLS N/A
- Revenue Growth
- BDC N/A
- APLS 97.02
- 52 Week Low
- BDC $80.90
- APLS $21.70
- 52 Week High
- BDC $131.82
- APLS $58.51
- Technical
- Relative Strength Index (RSI)
- BDC 40.81
- APLS 35.14
- Support Level
- BDC $97.43
- APLS $21.70
- Resistance Level
- BDC $106.97
- APLS $24.88
- Average True Range (ATR)
- BDC 2.59
- APLS 1.10
- MACD
- BDC 0.14
- APLS -0.05
- Stochastic Oscillator
- BDC 38.68
- APLS 25.26
About BDC Belden Inc
Belden Inc provides signal transmission products to distributors, end-users, installers, and original equipment manufacturers. The firm operates in two segments - Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions segment is a provider in network infrastructure and broadband solutions, as well as cabling and connectivity solutions for commercial audio/video and security applications. Automation Solutions segment provides network infrastructure and digitization solutions to enable customers to make data-based business decisions. It operates in Americas, EMEA and APAC, out of which maximum revenue from Americas.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.